| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 722995 | Null | 0.000284051704014449 | 0.22131809 |
| NSC 726441 | 4,11-dihydroxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-naphtho [2,3-f]indole-5,10-dione dihydrochloride | 0.000284051704014449 | 0.36977608 |
| NSC 58239 | A 80021F34 | 0.000316293616993019 | 0.41209387 |
| NSC 626715 | 10-EdAM | 0.000316293616993019 | 0.76713602 |
| NSC 724037 | Null | 0.000337797539144495 | 0.62363659 |
| NSC 753221 | 3-Hydroxy-10-fluoro-5.6-dihydro-6-imino-isoindolo[2,1a]quinoxaline | 0.000337797539144495 | 0.5800758 |
| NSC 728134 | 1-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-5-chloro-2-methoxybenzene | 0.00041605412594464 | 0.3371467 |
| NSC 173552 | L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate | 0.000455867606843412 | 0.84537115 |
| NSC 339579 | 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate | 0.000455867606843412 | 0.84919516 |
| NSC 371777 | Null | 0.000455867606843412 | 0.27261359 |